# Successful Erlotinib Rechallenge after Gefitinib-Induced Acute Interstitial Pneumonia

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/successful-erlotinib-rechallenge-after-gefitinib-induced-acute-interstitial/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Shih‐Chieh Chang,Cheng‐Yu Chang,Chiung‐Yu Chen,Chong‐Jen Yu |
| Citations | 34 |
| DOI | 10.1097/jto.0b013e3181dc39cd |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | http://www.jto.org/article/S155608641530561X/pdf |
| OpenAlex ID | https://openalex.org/W1984968232 |
| PMID | 20581580 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Cheng‐Yu Chang](https://scholariq.org/researchers/cheng-yu-chang/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.